These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8787121)

  • 1. Drug's link to genes reveals estrogen's many sides.
    Pennisi E
    Science; 1996 Aug; 273(5279):1171. PubMed ID: 8787121
    [No Abstract]   [Full Text] [Related]  

  • 2. Differing roles found for estrogen's two receptors.
    Pennisi E
    Science; 1997 Sep; 277(5331):1439. PubMed ID: 9304214
    [No Abstract]   [Full Text] [Related]  

  • 3. Raloxifene: magic bullet for heart and bone?
    Gustafsson JA
    Nat Med; 1998 Feb; 4(2):152-3. PubMed ID: 9461183
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene.
    Yang NN; Venugopalan M; Hardikar S; Glasebrook A
    Science; 1996 Aug; 273(5279):1222-5. PubMed ID: 8703055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: raloxifene response needs more than an element.
    Yang NN; Venugopalan M; Hardikar S; Glasebrook A
    Science; 1997 Feb; 275(5304):1249. PubMed ID: 9064777
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.
    Yang NN; Bryant HU; Hardikar S; Sato M; Galvin RJ; Glasebrook AL; Termine JD
    Endocrinology; 1996 May; 137(5):2075-84. PubMed ID: 8612550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An estrogen receptor basis for raloxifene action in bone.
    Bryant HU; Glasebrook AL; Yang NN; Sato M
    J Steroid Biochem Mol Biol; 1999; 69(1-6):37-44. PubMed ID: 10418979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.
    Grese TA; Pennington LD; Sluka JP; Adrian MD; Cole HW; Fuson TR; Magee DE; Phillips DL; Rowley ER; Shetler PK; Short LL; Venugopalan M; Yang NN; Sato M; Glasebrook AL; Bryant HU
    J Med Chem; 1998 Apr; 41(8):1272-83. PubMed ID: 9548817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and bone: new pieces to the puzzle.
    Raisz LG
    Nat Med; 1996 Oct; 2(10):1077-8. PubMed ID: 8837601
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.
    Paech K; Webb P; Kuiper GG; Nilsson S; Gustafsson J; Kushner PJ; Scanlan TS
    Science; 1997 Sep; 277(5331):1508-10. PubMed ID: 9278514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Picture story. Agony and antagonism.
    Smith TL
    Nat Struct Biol; 1997 Nov; 4(11):908. PubMed ID: 9360605
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular determinants of tissue selectivity in estrogen receptor modulators.
    Grese TA; Sluka JP; Bryant HU; Cullinan GJ; Glasebrook AL; Jones CD; Matsumoto K; Palkowitz AD; Sato M; Termine JD; Winter MA; Yang NN; Dodge JA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14105-10. PubMed ID: 9391160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal effects of estrogen analogs.
    Lindsay R; Cosman F
    Osteoporos Int; 1997; 7 Suppl 1():S40-2. PubMed ID: 9205645
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
    Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
    J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
    Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
    J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
    Sato M; Rippy MK; Bryant HU
    FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raloxifene: a selective estrogen receptor modulator.
    Scott JA; Da Camara CC; Early JE
    Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective estrogen receptor modulators and postmenopausal women's health: the promise for the next millennium.
    Agnusdei D
    Aging (Milano); 1998 Aug; 10(4):269-72. PubMed ID: 9825017
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity.
    Dodge JA; Lugar CW; Cho S; Short LL; Sato M; Yang NN; Spangle LA; Martin MJ; Phillips DL; Glasebrook AL; Osborne JJ; Frolik CA; Bryant HU
    J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):97-106. PubMed ID: 9328215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.
    Moyle-Heyrman G; Schipma MJ; Dean M; Davis DA; Burdette JE
    J Ovarian Res; 2016 Feb; 9():5. PubMed ID: 26879975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.